New drug HRS-3802 enters human testing for Hard-to-Treat cancers
NCT ID NCT06770569
First seen Jan 24, 2026 · Last updated May 22, 2026 · Updated 18 times
Summary
This early-phase study tests a new drug called HRS-3802 in about 100 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants will receive the drug alone and be closely monitored for side effects and any anti-cancer activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100021, China
Contact
-
GenesisCare North Shore (Oncology)
ACTIVE_NOT_RECRUITINGSaint Leonards, New South Wales, 2065, Australia
-
GenesisCare St Andrews
ACTIVE_NOT_RECRUITINGAdelaide, South Australia, 5000, Australia
-
John Flynn Private Hospital
ACTIVE_NOT_RECRUITINGTugun, Queensland, 4224, Australia
-
Macquarie University Hospital
ACTIVE_NOT_RECRUITINGSydney, New South Wales, 2109, Australia
-
Peninsula and South Eastern Haematology & Oncology Group
ACTIVE_NOT_RECRUITINGFrankston, Victoria, 3199, Australia
Conditions
Explore the condition pages connected to this study.